Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 19;13(1):127.
doi: 10.1186/s13756-024-01485-3.

Outbreak with OXA-23-producing Acinetobacter baumannii in a COVID-19 ICU cohort: unraveling routes of transmission

Sandra Zingg  1 , Sabine Kuster  1 , Matthias von Rotz  1 , Aurore Portmann  1 , Adrian Egli  2   3   4 , Helena M B Seth-Smith  2   3   4 , Pascal Schlaepfer  5 , Daniel Goldenberger  2 , Stefano Bassetti  6 , Stephan Marsch  7 , Hans Pargger  7 , Richard Kuehl  1 , Sarah Tschudin-Sutter  8
Affiliations

Outbreak with OXA-23-producing Acinetobacter baumannii in a COVID-19 ICU cohort: unraveling routes of transmission

Sandra Zingg et al. Antimicrob Resist Infect Control. .

Abstract

An outbreak of OXA-23-producing carbapenem-resistant Acinetobacter baumannii amongst ICU-patients with COVID-19 likely occurred by transmission through inanimate surfaces, potentially facilitated by a contaminated positioning pillow shared between patients. Subsequent rapid spread may have been caused by exposure to respiratory secretions contaminating healthcare worker's gloves and gowns during prone positioning.

PubMed Disclaimer

Conflict of interest statement

S. Tschudin-Sutter serves as editor of the journal Antimicrobial Resistance and Infection Control.

Figures

Fig. 1
Fig. 1
Floor plan of the COVID-19  cohort within the intensive care unit. Red circle: index patient with OXA-23-producing Acinetobacter baumannii in 07/2021; purple circles: patients with detection of OXA-23-producing A. baumannii throughout the cohort within six days, two months later
See this image and copyright information in PMC

References

    1. CDC, COVID-19:. U.S. Impact on Antimicrobial Resistance, Special Report 2022. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2022. https://www.cdc.gov/drugresistance/covid19.html.
    1. Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19. Erratum in: Lancet. 2022;400(10358):1102. PMID: 35065702; PMCID: PMC8841637. - PMC - PubMed
    1. Higgins PG, Prior K, Harmsen D, Seifert H. Development and evaluation of a core genome multilocus typing scheme for whole-genome sequence-based typing of Acinetobacter baumannii. PLoS ONE. 2017;12(6):e0179228. 10.1371/journal.pone.0179228. PMID: 28594944; PMCID: PMC5464626. - PMC - PubMed
    1. Wick RR, Judd LM, Gorrie CL, Holt KE. Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol. 2017;13(6):e1005595. 10.1371/journal.pcbi.1005595. - PMC - PubMed
    1. Gottesman T, Fedorowsky R, Yerushalmi R, Lellouche J, Nutman A. An outbreak of carbapenem-resistant Acinetobacter baumannii in a COVID-19 dedicated hospital. Infect Prev Pract. 2021;3(1):100113. 10.1016/j.infpip.2021.100113. Epub 2021 Jan 9. PMID: 34316574; PMCID: PMC7794049. - PMC - PubMed